Watch For: Top of the Therapeutic Window -This comment on Vyvanse is worth your time, and is so commonly seen in the office. Vyvanse in the PM is so forgiving - that when it finishes, it is hard to assess. Measure the DOE anyway - start with that process.
The AD/HD Philosophic Reception: The medical discussion about aspects of my new book has been, quite interestingly, uniformly positive. The theme in my medical presentations is simple, and often addressed here at CorePsychBlog - we often do not use precise parameters with our AD/HD treatment targets, - current diagnostic criteria are imprecise, superficial, amorphous and "move about" too much- does that cover it? If we don't see it how can we hit it? - we don't appreciate the specific trajectories of the drugs we use, and thereby often miss the mark just because we don't adjust our sights correctly, but, rather, too often blast away. Are we shooting howitzers at wrens?